Skip to content

Federal Contractor Profile

Department Of Health

$116M obligated·73 awards·3 agencies·16 NAICS

Federal Contracts

Showing award actions 1–50 of 148 funded award actions, most recent first.

Contracts with positive obligations
73
Funded award actions shown
148
Obligations shown
$116M
Awarding agencies
3

This table shows award actions with a positive obligation. Zero-dollar and negative-dollar actions, such as administrative changes and deobligations, are not displayed. Multiple award actions may belong to the same contract.

Award data as of November 5, 2026. Source: USAspending federal award records.

DateAgencyPIIDNAICSDescriptionAmount
Aug 6, 2026Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES75D30126P213939231302026 NDI EO 14398$122
Jun 2, 2026Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40126F19002923120TASK ORDER - AMERICAN SAMOA STATE TOBACCO RETAIL COMPLIANCE INSPECTIONS IDIQ CONTRACT$199K
May 19, 2026Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0032541715NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS$240K
May 18, 2026Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA124C0008541714GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE.$2.0M
Jan 22, 2026Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0032541715NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS$650K
Jan 7, 2026Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA124C0008541714GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE.$1.5M
Dec 15, 2025Department of Health and Human ServicesFDA OFFICE OF ACQ GRANT SVCS75F40126F19001923120AMERICAN SAMOA STATE TOBACCO RETAIL COMPLIANCE INSPECTIONS - TASK ORDER$116K
Aug 5, 2025Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0032541715NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS$400K
Jul 30, 2025Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA124C0008541714GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE.$779K
Jun 11, 2025Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA124C0008541714GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE.$221K
May 15, 2025Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0035541715FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK$104K
Mar 6, 2025Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA124C0008541714GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE.$186K
Feb 19, 2025Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA124C0008541714GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE.$386K
Feb 13, 2025Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0032541715NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS$713K
Feb 6, 2025Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA120C0016541714PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS$245K
Sep 17, 2024Department of DefenseNAVAL AIR SYSTEMS COMMANDN0001924C0045336413CWB KITS & SHIPPING FIXTURE$9.1M
Sep 10, 2024Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0035541715FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK$232K
Jun 25, 2024Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA120C0016541714PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS$125K
Jun 11, 2024Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0035541715FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK$99K
Jun 6, 2024Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA124C0008541714GENERATION OF A NOVEL ANTIBODY-ANTIBIOTIC CONJUGATE AS A COMBINATION THERAPY PLATFORM TO TREAT MELIOIDOSIS OR PLAGUE.$535K
Apr 18, 2024Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0032541715NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS$1.4M
Mar 4, 2024Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0035541715FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK$75K
Jan 10, 2024Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA120C0016541714PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS$125K
Nov 8, 2023Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0032541715NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS$1.3M
Sep 25, 2023Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0035541715FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK$86K
Aug 14, 2023Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA120C0016541714PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS$205K
Aug 1, 2023Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0035541715FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK$154K
Jul 28, 2023Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0032541715NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS$608K
Sep 29, 2022Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0035541715FUNDAMENTAL RESEARCH OF A DEEP LEARNING DEVELOPMENT AND EVALUATION FRAMEWORK$120K
Sep 28, 2022Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA122C0032541715NON IONIC SURFACTANT VESICLES (NISVS) AS A DRUG DELIVERY AND TARGETING SYSTEMS FOR ANTIMICROBIALS$200K
Aug 18, 2022Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA120C0016541714PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS$165K
Jun 14, 2022Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA120C0016541714PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS$20K
Sep 29, 2021Department of Health and Human ServicesNIH NCIHHSN261201700038P519130IGF::OT::IGF OTHER FUNCTIONS - CLINICAL PRACTICE RESEARCH DATALINK (CPRD) DATABASE ACCESS.$127K
Sep 22, 2021Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA119C0001541714HARNESSING NATURAL REGULATORS TO COMBAT ANTI-MICROBIAL RESISTANCE (AMR)$915K
Sep 16, 2021Department of Health and Human ServicesNIH NCI75N91021F00004541713LICENSE TO THE CLINICAL PRACTICE RESEARCH DATALINK (CPRD) NATIONAL CANCER DATA REGISTRY (NCDR) DATABASE$173K
Aug 16, 2021Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA117C0028541712CRYSTALCAST TOOLSET IGF::OT::IGF$15K
Jun 30, 2021Department of DefenseNAVAL AIR SYSTEMS COMMANDN0001921C0045336411E-3D AIRCRAFT (TAIL NUMBER ZH104)$15M
Jun 22, 2021Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA120C0004541714DEVELOPMENT OF AN INHALATION MODEL OF EEEV IN THE COMMON MARMOSET.$757K
Jun 9, 2021Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA120C0016541714PHARMACOLOGICAL AND BIOLOGIC INTERVENTION TO REDUCE INFLAMMATION AND SEIZURES CAUSED BY VIRAL ENCEPHALITIS$230K
Jun 8, 2021Department of DefenseFA7014 AFDW PKFA701421P0006928120PKH-MCCRAY-AUBOURG RATIFICATION OF UNAUTHORIZED COMMITMENT: UNITED KINGDOM HIGHER COMMAND AND STAFF COURSE (HCSC)$68K
Jun 4, 2021Department of Health and Human ServicesCDC OFFICE OF ACQUISITION SERVICES75D30121P11111518210AMERICAN SAMOA NDI 2021$109
May 18, 2021Department of Health and Human ServicesNIH NCI75N91021F00003541713DEPARTMENT OF HEALTH:1259246 [21-026016]$13K
May 5, 2021Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA119C0001541714HARNESSING NATURAL REGULATORS TO COMBAT ANTI-MICROBIAL RESISTANCE (AMR)$773K
Apr 19, 2021Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA118C0065541714BIOLOGICAL AGENT DIAGNOSTIC LEXICON FOR CLINICAL INFORMATION EXPLOITATION$231K
Mar 23, 2021Department of Health and Human ServicesNIH NCI75N91021F00001541713LINKAGE OF CLINICAL PRACTICE RESEARCH DATALINK (CPRD) TO THE NATIONAL CANCER DATA REGISTRY (NCDR) DATABASE FOR THE STUDY: HORMONE THERAPY IN RELATION TO RISKS OF SECOND CANCERS AND MORTALITY AMONG WOMEN AND MEN.$15K
Mar 23, 2021Department of Health and Human ServicesNIH NCI75N91021F00002541713LINKAGE OF CLINICAL PRACTICE RESEARCH DATALINK (CPRD) TO THE NATIONAL CANCER DATA REGISTRY (NCDR) DATABASE FOR THE STUDY: REPRODUCTIVE RISK FACTORS FOR PROSTATE CANCER INCIDENCE, MORTALITY AND SURVIVAL.$15K
Mar 2, 2021Department of DefenseDEFENSE THREAT REDUCTION AGENCY0019541711BASE PERIOD IGF::OT::IGF$881K
Nov 25, 2020Department of DefenseDEFENSE THREAT REDUCTION AGENCYHDTRA118C0065541714BIOLOGICAL AGENT DIAGNOSTIC LEXICON FOR CLINICAL INFORMATION EXPLOITATION$5K
Nov 24, 2020Department of DefenseDEFENSE THREAT REDUCTION AGENCY0020541711ANTHRAX DETECTION - BASE IGF::OT::IGF$108K
Sep 24, 2020Department of Health and Human ServicesNIH NCI75N91020F00001541713PROCUREMENT OF A LICENSE FOR 12 MONTHS OF ACCESS TO NATIONAL LIBRARY OF MEDICINE - UK CPRD DATASETS$160K

Get Alerted Before Department Of Health's Next Recompete

Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.

Start for free